Povorcitinib 75 mg achieved high-threshold lesion clearance by week 12, including 100% draining-tunnel reduction in 12%–57% and total abscess clearance in 22%–62% of participants. Phase 3 data show ...
ClinCapture announces AI-powered clinical trial build tech that automates study configuration, and advances intelligent ...
CHOP receives $10 million grant for project that uses clinical data analysis to combat rare diseases
The Center for Data Driven Discovery in Biomedicine at the Children's Hospital of Philadelphia received a $10 million federal grant for the development of Real-time Analysis and Discovery in ...
A research team has developed a versatile machine learning model that could one day greatly expand what medical scans can tell us about disease. Scientists used their tool, named Merlin, to assess 3D ...
Cancer patients' messages about radiology/pathology reports: Insights for AI. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include a full text component ...
As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...
Q4 2025 Management View CEO David Chang described 2026 as a “defining year” focused on “delivering meaningful clinical milestones with rigor and speed.” He emphasized that Allogene’s approach is to ...
Brentwood, Tenn.-based HealthTrust Purchasing Group has acquired certain assets of Cardiac Data Solutions, an analytic platform that helps healthcare leaders improve clinical and financial outcomes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results